Basel Medical Group’s shares have dropped by approximately 15% following the company’s announcement of its intention to purchase $1 billion in Bitcoin for its corporate treasury. The Singapore-based healthcare company revealed its plans to acquire the cryptocurrency through a share-swap arrangement with a consortium of institutional investors and high-net-worth individuals. Basel Medical Group aims to strengthen its balance sheet, enhance financial flexibility for mergers and acquisitions, and diversify its asset base to mitigate market volatility through this strategic move. However, shareholders have reacted negatively to the news, with the company’s stock, BMGL, experiencing a significant decline. In a similar scenario, GameStop faced a $3 billion market capitalization loss in a single trading day in March after revealing its Bitcoin accumulation plans. Corporate treasuries collectively hold approximately $80 billion worth of Bitcoin, offering a potential hedge against fiscal deficits, currency devaluation, and geopolitical risks. Basel Medical Group’s management anticipates that accumulating Bitcoin will support its expansion strategy in the Southeast Asian healthcare market. The company recently acquired Bethesda Medical, marking the beginning of its growth plans in the region. CEO Darren Chhoa expressed confidence that the expanded balance sheet will enable Basel Medical Group to pursue strategic opportunities efficiently. The trend of companies building Bitcoin treasuries is gaining traction, with Fidelity Digital Assets highlighting the cryptocurrency’s value as a risk management tool for corporations. As the market continues to evolve, the impact of Bitcoin acquisitions on share prices remains a topic of interest for investors.